Architectural Oncology defines malignancy as a persistently executable state. Persistence is determined not by the activity of individual molecular pathways, but by whether cell-wide coordination remains feasible under sustained oncogenic demand.
Molecular perturbations may alter signaling outputs, but do not necessarily compromise executability. The central problem of cancer control, therefore, is identifying the conditions under which execution becomes infeasible.
